XML 144 R124.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidating Financial Statements - Consolidating Statements of Income (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Condensed Income Statements, Captions [Line Items]                      
Dialysis and related lab patient service revenues                 $ 10,093,670 $ 9,727,360 $ 9,155,447
Less: Provision for uncollectible accounts                 (485,398) (431,308) (412,905)
Net dialysis and related lab patient service revenues                 9,608,272 9,296,052 8,742,542
Other revenues                 1,268,362 1,411,415 1,239,703
Total net revenues $ 2,780,913 $ 2,765,071 $ 2,699,399 $ 2,631,251 $ 2,699,419 $ 2,725,407 $ 2,675,474 $ 2,607,167 10,876,634 10,707,467 9,982,245
Operating expenses and charges                 9,063,879 8,677,757 8,845,479
Operating income 150,337 395,294 391,196 875,928 363,445 813,103 431,129 422,033 1,812,755 2,029,710 1,136,766
Debt expense                 (430,634) (414,116) (408,380)
Debt (expense) and refinancing charges                     (456,452)
Other income, net                 17,665 7,511 8,073
Income tax expense                 323,859 431,761 207,510
Equity earnings in subsidiaries                 0 0 0
Net income from continuing operations                 1,075,927 1,191,344 480,877
Net loss from discontinued operations, net of tax                 (245,372) (158,262) (53,467)
Net income                 830,555 1,033,082 427,410
Less: Net income attributable to noncontrolling interests                 (166,937) (153,208) (157,678)
Net income attributable to DaVita Inc. $ 303,396 $ (214,476) $ 127,001 $ 447,697 $ 157,726 $ 571,332 $ 53,382 $ 97,434 663,618 879,874 269,732
Consolidating Adjustments                      
Condensed Income Statements, Captions [Line Items]                      
Dialysis and related lab patient service revenues                 (184,106) (153,326) (131,164)
Less: Provision for uncollectible accounts                 7,170 0 0
Net dialysis and related lab patient service revenues                 (176,936) (153,326) (131,164)
Other revenues                 (798,212) (765,516) (720,804)
Total net revenues                 (975,148) (918,842) (851,968)
Operating expenses and charges                 (975,148) (918,842) (851,968)
Operating income                 0 0 0
Debt expense                 239,958 225,326  
Debt (expense) and refinancing charges                     203,985
Other income, net                 (423,702) (400,706) (365,861)
Income tax expense                 0 0 0
Equity earnings in subsidiaries                 (552,567) (1,360,998) (496,979)
Net income from continuing operations                 (736,311) (1,536,378) (658,855)
Net loss from discontinued operations, net of tax                 183,744 175,380 161,876
Net income                 (552,567) (1,360,998) (496,979)
Less: Net income attributable to noncontrolling interests                 (166,937) (153,208) (157,678)
Net income attributable to DaVita Inc.                 (719,504) (1,514,206) (654,657)
DaVita Inc. | Reportable Legal Entites                      
Condensed Income Statements, Captions [Line Items]                      
Dialysis and related lab patient service revenues                 0 0 0
Less: Provision for uncollectible accounts                 0 0 0
Net dialysis and related lab patient service revenues                 0 0 0
Other revenues                 793,751 767,791 727,887
Total net revenues                 793,751 767,791 727,887
Operating expenses and charges                 527,942 493,175 488,595
Operating income                 265,809 274,616 239,292
Debt expense                 (426,149) (407,925)  
Debt (expense) and refinancing charges                     (449,598)
Other income, net                 411,731 396,797 365,752
Income tax expense                 65,965 77,334 60,671
Equity earnings in subsidiaries                 478,192 693,720 174,957
Net income from continuing operations                 663,618 879,874 269,732
Net loss from discontinued operations, net of tax                 0 0 0
Net income                 663,618 879,874 269,732
Less: Net income attributable to noncontrolling interests                 0 0 0
Net income attributable to DaVita Inc.                 663,618 879,874 269,732
Guarantor Subsidiaries | Reportable Legal Entites                      
Condensed Income Statements, Captions [Line Items]                      
Dialysis and related lab patient service revenues                 6,884,750 6,665,601 6,471,702
Less: Provision for uncollectible accounts                 (340,586) (272,430) (281,976)
Net dialysis and related lab patient service revenues                 6,544,164 6,393,171 6,189,726
Other revenues                 1,204,501 1,378,956 1,208,607
Total net revenues                 7,748,665 7,772,127 7,398,333
Operating expenses and charges                 6,475,550 6,907,469 6,925,234
Operating income                 1,273,115 864,658 473,099
Debt expense                 (209,612) (191,083)  
Debt (expense) and refinancing charges                     (178,389)
Other income, net                 11,169 3,726 1,261
Income tax expense                 237,670 238,446 163,401
Equity earnings in subsidiaries                 74,375 667,278 322,022
Net income from continuing operations                 911,377 1,106,133 454,592
Net loss from discontinued operations, net of tax                 (433,185) (412,413) (279,635)
Net income                 478,192 693,720 174,957
Less: Net income attributable to noncontrolling interests                 0 0 0
Net income attributable to DaVita Inc.                 478,192 693,720 174,957
Non- Guarantor Subsidiaries | Reportable Legal Entites                      
Condensed Income Statements, Captions [Line Items]                      
Dialysis and related lab patient service revenues                 3,393,026 3,215,085 2,814,909
Less: Provision for uncollectible accounts                 (151,982) (158,878) (130,929)
Net dialysis and related lab patient service revenues                 3,241,044 3,056,207 2,683,980
Other revenues                 68,322 30,184 24,013
Total net revenues                 3,309,366 3,086,391 2,707,993
Operating expenses and charges                 3,035,535 2,195,955 2,283,618
Operating income                 273,831 890,436 424,375
Debt expense                 (34,831) (40,434)  
Debt (expense) and refinancing charges                     (32,450)
Other income, net                 18,467 7,694 6,921
Income tax expense                 20,224 115,981 (16,562)
Equity earnings in subsidiaries                 0 0 0
Net income from continuing operations                 237,243 741,715 415,408
Net loss from discontinued operations, net of tax                 4,069 78,771 64,292
Net income                 241,312 820,486 479,700
Less: Net income attributable to noncontrolling interests                 0 0 0
Net income attributable to DaVita Inc.                 $ 241,312 $ 820,486 $ 479,700